Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Sep;86(3):723-7.
doi: 10.1172/JCI114768.

Thyroid-stimulating antibody activity between different immunoglobulin G subclasses

Affiliations

Thyroid-stimulating antibody activity between different immunoglobulin G subclasses

A P Weetman et al. J Clin Invest. 1990 Sep.

Abstract

To investigate the distribution of thyroid-stimulating antibody (TSAb) activity between IgG subclasses, sera from 11 patients with Graves disease (including the National Institute of Biological Standards and Control (NIBSC) Research Standard, long acting thyroid stimulator-B) were fractionated by chromatography on affinity columns of monoclonal IgG subclass antibodies or protein A to deplete all but a single subclass. The resulting fractions were 98% or more pure for a single subclass. In all 11 patients, TSAb activity appeared to be confined to the IgG1 fraction as determined by cAMP production on addition of the fractions to the FRTL-5 rat thyroid cell line. In all of eight specimens from seven patients so tested, the whole serum activity was recovered in the IgG1 fraction, after adjusting for the recovery of the isotype from the column. TSAb activity in one serum comprised both lambda and kappa light chains but was IgG1 restricted. This IgG subclass restriction was not found when the same fractions were tested for thyroglobulin, microsomal/thyroid peroxidase, or tetanus toxoid antibody activity. Together with previous results showing marked restriction of both light chain usage and isoelectric point of TSAb, these results support the idea that Graves' disease may be the result of an oligo- or possibly monoclonal response at the B cell level.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adv Immunol. 1974;19(0):259-94 - PubMed
    1. Proc Natl Acad Sci U S A. 1964 Aug;52:342-9 - PubMed
    1. Recent Prog Horm Res. 1976;33:29-57 - PubMed
    1. Endocrinology. 1978 Oct;103(4):1469-75 - PubMed
    1. Clin Exp Immunol. 1982 Apr;48(1):196-200 - PubMed

Publication types

MeSH terms